English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/81818
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Iodine supplementation during pregnancy: a public health challenge

AuthorsBerbel, Pere; Obregón, María Jesús; Bernal, Juan ; Escobar del Rey, Francisco; Morreale de Escobar, Gabriella
Issue Date2007
CitationTrends in Endocrinology and Metabolism 18(9): 338-343 (2007)
AbstractIodine deficiency remains the most frequent cause worldwide, after starvation, of preventable mental retardation in children. It causes maternal hypothyroxinemia, which affects pregnant women even in apparently iodine-sufficient areas, and often goes unnoticed because L-thyroxine (T4) levels remain within the normal range, and thyroid-stimulating hormone (TSH) is not increased. Even a mild hypothyroxinemia during pregnancy increases the risk of neurodevelopmental abnormalities, and experimental data clearly demonstrate that it damages the cortical cytoarchitecture of the fetal brain. The American Thyroid Association (ATA) recommends a supplement of 150 μg iodine/day during pregnancy and lactation, in addition to the use of iodized salt. We discuss the importance of iodine supplementation to ensure adequate T4 levels in all women who are considering conception and throughout pregnancy and lactation. © 2007 Elsevier Ltd. All rights reserved.
Identifiersdoi: 10.1016/j.tem.2007.08.009
issn: 1043-2760
e-issn: 1879-3061
Appears in Collections:(IIBM) Artículos
(IN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.